TY - JOUR AU - Congdon, N. AU - O’Colmain, B. AU - Klaver, C. C. PY - 2004 DA - 2004// TI - Causes and prevalence of visual impairment among adults in the United States JO - Arch Ophthalmol VL - 122 UR - https://doi.org/10.1001/archopht.122.4.477 DO - 10.1001/archopht.122.4.477 ID - Congdon2004 ER - TY - STD TI - World Helath Organization (WHO). Global report on diabetes. 2016. http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf?ua=1&ua=1. Accessed 26 Apr 2019. UR - http://apps.who.int/iris/bitstream/10665/204871/1/9789241565257_eng.pdf%3fua%3d1%26ua%3d1 ID - ref2 ER - TY - JOUR AU - Solomon, S. D. AU - Lindsley, K. AU - Vedula, S. S. PY - 2019 DA - 2019// TI - Anti-vascular endothelial growth factor for neovascular age-related macular degeneration JO - Cochrane Database Syst Rev VL - 3 ID - Solomon2019 ER - TY - JOUR AU - Solomon, S. D. AU - Chew, E. AU - Duh, E. J. PY - 2017 DA - 2017// TI - Diabetic retinopathy: a position statement by the american diabetes association JO - Diabetes Care VL - 40 UR - https://doi.org/10.2337/dc16-2641 DO - 10.2337/dc16-2641 ID - Solomon2017 ER - TY - JOUR AU - Rofagha, S. AU - Bhisitkul, R. B. AU - Boyer, D. S. PY - 2013 DA - 2013// TI - Seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP) JO - Ophthalmology VL - 120 UR - https://doi.org/10.1016/j.ophtha.2013.03.046 DO - 10.1016/j.ophtha.2013.03.046 ID - Rofagha2013 ER - TY - JOUR AU - Wykoff, C. C. AU - Ou, W. C. AU - Khurana, R. N. PY - 2018 DA - 2018// TI - Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study JO - Br J Ophthalmol VL - 102 UR - https://doi.org/10.1136/bjophthalmol-2017-310941 DO - 10.1136/bjophthalmol-2017-310941 ID - Wykoff2018 ER - TY - STD TI - Study of the efficacy and safety of the ranibizumab port delivery system (RPDS) for sustained delivery of ranibizumab in participants with subfoveal neovascular age-related macular degeneration (AMD) (LADDER). ClinicalTrials.gov Identifier: NCT02510794. ID - ref7 ER - TY - STD TI - A Phase III study to evaluate the port delivery system implant with ranibizumab compared with monthly ranibizumab injections in participants with wet age-related macular degeneration (Archway). ClinicalTrials.gov Identifier: NCT03677934. ID - ref8 ER - TY - STD TI - Dugel PU, Koh A, Ogura Y, et al. HAWK and HARRIER: phase 3, multicenter, randomized, double-masked trials of brolucizumab for neovascular age-related macular degeneration. Ophthalmology. 2019 (In press). ID - ref9 ER - TY - STD TI - A depot formulation of sunitinib malate (GB-102) in subjects with neovascular (wet) age-related macular degeneration. ClinicalTrials.gov Identifier: NCT03249740. ID - ref10 ER - TY - STD TI - RGX-314 gene therapy for neovascular AMD trial. ClinicalTrials.gov Identifier: NCT03066258. ID - ref11 ER - TY - STD TI - ADVM-022 gene therapy for wet AMD (OPTIC). ClinicalTrials.gov Identifier: NCT03748784. ID - ref12 ER - TY - STD TI - PANORAMA, Study of the efficacy and safety of intravitreal aflibercept for the improvement of moderately severe to severe NPDR. ClinicalTrials.gov:NCT02718326). ID - ref13 ER - TY - STD TI - IAI versus sham as prophylaxis against conversion to neovascular AMD (PRO-CON). ClinicalTrials.gov Identifier: NCT02462889. ID - ref14 ER - TY - JOUR AU - Nebbioso, M. AU - Lambiase, A. AU - Cerini, A. PY - 2019 DA - 2019// TI - Therapeutic approaches with intravitreal injections in geographic atrophy secondary to age-related macular degeneration: current drugs and potential molecules JO - Int J Mol Sci VL - 20 UR - https://doi.org/10.3390/ijms20071693 DO - 10.3390/ijms20071693 ID - Nebbioso2019 ER - TY - STD TI - Study of of APL-2 therapy in patients geographic atrophy (FILLY). ClinicalTrials.gov Identifier: NCT02503332. ID - ref16 ER - TY - STD TI - Study to compare the efficacy and safety of intravitreal APL-2 therapy with sham injections in patients with geographic atrophy (GA) secondary to age-related macular degeneration. ClinicalTrials.gov Identifier: NCT03525600. ID - ref17 ER - TY - STD TI - Study of photobiomodulation to treat dry age-related macular degeneration (LIGHTSITE II). ClinicalTrials.gov Identifier: NCT03878420. ID - ref18 ER - TY - STD TI - AAVCAGsCD59 for the treatment of wet AMD. ClinicalTrials.gov Identifier: NCT03585556. ID - ref19 ER - TY - STD TI - Suprachoroidal injection of CLS-TA in subjects with macular edema associated with non-infectious uveitis (PEACHTREE). ClinicalTrials.gov Identifier: NCT02595398. ID - ref20 ER - TY - STD TI - Study of comparative treatments for retinal vein occlusion 2 (SCORE2). ClinicalTrials.gov Identifier: NCT01969708. ID - ref21 ER - TY - JOUR AU - Kashani, A. H. AU - Chen, C. L. AU - Gahm, J. K. PY - 2017 DA - 2017// TI - Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications JO - Prog Retin Eye Res. VL - 60 UR - https://doi.org/10.1016/j.preteyeres.2017.07.002 DO - 10.1016/j.preteyeres.2017.07.002 ID - Kashani2017 ER - TY - JOUR AU - Thulliez, M. AU - Motulsky, E. H. AU - Feuer, W. PY - 2019 DA - 2019// TI - En face imaging of geographic atrophy using different swept-source OCT scan patterns JO - Ophthalmol Retina. VL - 3 UR - https://doi.org/10.1016/j.oret.2018.09.004 DO - 10.1016/j.oret.2018.09.004 ID - Thulliez2019 ER - TY - JOUR AU - Zheng, F. AU - Zhang, Q. AU - Shi, Y. PY - 2019 DA - 2019// TI - Age-dependent changes in the macular choriocapillaris of normal eyes imaged with swept-source optical coherence tomography angiography JO - Am J Ophthalmol VL - 200 UR - https://doi.org/10.1016/j.ajo.2018.12.025 DO - 10.1016/j.ajo.2018.12.025 ID - Zheng2019 ER -